E

Emergent Biosolutions
D

EBS

8.42000
USD
-0.07
(-0.82%)
Pre Open·8.59000USD+0.17000(+2.02%)
Volume
7,133
EPS
-0
Div Yield
-
P/E
-44
Market Cap
434,440,812
Overview
Related Instruments
A
AMTD
D
0.95010
-0.00020(-0.02%)
CME
CME
D
219.110
-1.670(-0.76%)
221.400+2.290(+1.05%)
IBKR
IBKR
D
87.910
-1.840(-2.05%)
90.290+2.380(+2.71%)
ICE
ICE
D
122.600
-1.240(-1.00%)
125.250+2.650(+2.16%)
M
MC
D
61.620
-2.870(-4.45%)
64.700+3.080(+5.00%)
MS
MS
D
213.790
1.480(0.70%)
212.810-0.980(-0.46%)
NDAQ
NDAQ
D
77.630
-0.830(-1.06%)
78.800+1.170(+1.51%)
SCHW
SCHW
D
90.810
0.700(0.78%)
90.500-0.310(-0.34%)
More

Title: Emergent Biosolutions

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consistingof Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Smarter Decisions,Together
FacebookTwitterYoutubeLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.